Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
about
MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblastsGinsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation.The Hyaluronic Acid-HDAC3-miRNA Network in Allergic Inflammation.Post-transcriptional regulation of BRCA1 through its coding sequence by the miR-15/107 group of miRNAs.Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLCHistone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.Downregulation of growth differentiation factor-15 in trichostatin A-induced apoptosis could play a role in progression of gastric cancer.miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.Differential expression of glycoprotein non-metastatic melanoma protein B (GPNMB) involved in trichostatin A-induced apoptosis in gastric cancer.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerEffect of trichostatin a on SGC-7901 gastric cancer cells.Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells.
P2860
Q33982509-C6F15DB4-9F36-4DEA-B1B0-F250C9CE93D8Q34734168-EB1C3226-619D-4738-B319-EC5659F44504Q35556498-D0B33F43-7A4C-46A5-99C5-7054A02B5134Q35884235-B4070E84-23E7-42CF-A4A7-4FA9CBC0BB07Q37635781-0B3FBD4E-96E1-4AB5-AE99-2D7E3B77CD2EQ37645002-43823D99-D007-4EBB-A49D-B9B446F205F8Q38376048-F4CE02D9-9C16-4196-AE2D-0D3ABE61A7BFQ38572855-81F3736E-A993-4E84-8F60-901F3EDB4265Q38707876-8CB2D97F-9D94-4A45-ACC5-5CAD0180336CQ38837934-AE33945E-42C8-418E-993F-5A9DD492B213Q38840273-EDAB51C7-0E95-46CD-8521-19A4384BA935Q38911571-A36F2021-24EB-4EC5-8E91-E2CAB3B03ADFQ41552614-5E17ABAE-4395-4AAF-9C90-A1347F83B0B9Q42873813-5A71F8E2-46E2-4FEC-ACA8-FCB50DFBF823Q47787181-36A911E3-7B83-4B9E-BD1A-0A7562CCF70B
P2860
Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@en
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@nl
type
label
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@en
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@nl
prefLabel
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@en
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@nl
P2093
P2860
P1476
Histone deacetylases inhibitor ...... in non-small cell lung cancer.
@en
P2093
Cheng-Shui Chen
Chi-Qi Chen
Hong-Lei Xu
Jian-Bo Wu
Jun-Jie Chen
Lian-Ping Zhou
Shen-Meng Gao
Wei-Wei Jin
P2860
P2888
P304
P356
10.1007/S11010-013-1762-Z
P577
2013-07-19T00:00:00Z